Patients Stopping Weight-Loss Jabs Gain Back Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

A recent study suggests that individuals who stop using popular weight-loss injections like Wegovy and Mounjaro tend to recover lost weight much more quickly than those who end traditional lifestyle regimens.

Published data in a prominent health publication points out that while obese people can lose a large proportion of their body weight while on the medication, the weight comes back at an average rate of nearly a kilo each month once they quit.

"Individuals using these drugs need to be cognizant of the danger of fast rebound weight gain when the therapy ends," cautioned expert Dr. Susan Jebb.

That rate of regain implies a reversion to starting weight in about 18 months.

Analyzing Therapies

The research, which looked at 37 of trials involving thousands of patients, compared the results of GLP-1 agonists with older methods.

The team point out that individuals who lose weight through lifestyle changes alone generally see a more gradual creep back—around 100 grams monthly—once they finish.

Understanding the Fast Rebound

Experts suggest the way of the injections is key to understanding the accelerated weight return.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.

"Sustained high doses of the hormone concentrations several times higher than normal could lead to the system to produce less of its own natural hormone, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.

"Stopping of this GLP-1 'fix' means hunger is unsuppressed, making excessive eating much more probable."

An Ongoing Disease?

The NHS recommend the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians say that, due to the likelihood of weight regain, the therapy might need to be life-long.

This opinion is supported by pharmaceutical companies, who state that the findings "highlight the persistent nature of excess weight," comparing it to managing conditions like hypertension.

User Experiences

Individuals who have stopped the jabs describe a intense resurgence of appetite.

"It felt as if a trigger flipping and you become extremely hungry," recalled one woman.

This difficulty is exacerbated if individuals have not developed permanent lifestyle or habit modifications during treatment.

Widespread Interest

Figures show that a significant number of adults in the UK have used these injections in the last 12 months, with interest remaining high.

• Adoption is higher among women than males.
• The 40s and 50s age group shows the greatest level of interest.
• Many access the drugs through private healthcare rather than public health services.

In conclusion, clinicians emphasize that while these medications are potent agents for weight loss, they are not a standalone fix and maintained weight loss relies on combined behavioural changes.